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Limb regeneration: Re-entering the cell cycle
David L. Stocum
Understanding the cellular plasticity that enables
urodeles to regenerate many tissues is important for
determining why mammals repair those same tissues
with scar. The answer may lie partly in a recently
discovered differential responsiveness of urodele cells
to factors present in serum at the wound site.
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Mammals can regenerate some, but not all, tissues after
wounding — for example, unlike some amphibians they
cannot regenerate lost limbs. Mammalian tissues such as
epithelia, blood, bone and muscle are continually or
readily regenerated via stem or progenitor cells that are set
aside for this purpose during fetal life. The central
nervous system also has a limited regenerative capacity
mediated by neural stem cells. The liver contains stem
cells that are activated for regeneration only in cases of
extreme damage; otherwise the liver regenerates by com-
pensatory hyperplasia. But urodele amphibians — the
salamanders and newts — can regenerate a number of
tissues and complex structures that mammals cannot: lens,
neural retina, spinal cord, upper and lower jaws, tails and
limbs [1]. The unique feature underlying the regeneration
of these structures is their ability to form a blastema of
progenitor cells via the dedifferentiation of mature cells.
The blastema grows and redifferentiates into exactly those
parts that were damaged or lost.
Blastema formation by dedifferentiation has been best
studied in regenerating urodele limbs. Amputation of the
limb triggers the breakdown of extracellular matrix at the
wound site, liberating fibroblasts, chondrocytes or
osteocytes, myofibers and Schwann sheath cells from their
tissue organization. Matrix degradation is achieved by the
upregulation of proteases [2–5], particularly the acid
hydrolases cathepsin D and acid phosphatase, and the
matrix metalloproteinases (MMPs), particularly MMP-9
(gelatinase b), MMP-3/10a (stomelysin 1) and MMP-3/10b
(stromelysin 2). Many light and electron microscope
studies have suggested that the liberated cells lose their
phenotypic specializations to become undifferentiated
mesenchymal progenitor cells that re-enter the cell cycle
and proliferate to form the regeneration blastema.
Experiments in which labeled chondrocytes and myofibers
were implanted into limb stumps or early regeneration
blastemas have confirmed that these cell types dedifferen-
tiate and become part of the blastema [1,6]. Myofiber ded-
ifferentiation is particularly interesting because these
multinucleate cells must be broken up into undifferenti-
ated mononucleate cells.
What endows the urodeles with this remarkable degree of
cellular plasticity in the face of injury? There might be dif-
ferences between urodeles and mammals in the molecular
signals of the wound environment that allow cells (particu-
larly fibroblasts) to proliferate, which in mammals divert
them into pathways leading to scar tissue formation and in
urodeles into pathways of dedifferentiation and regenera-
tion. Alternatively, urodelean and mammalian wound
environments might be similar, but the cellular responses
to these environments might differ. Little information is
available to support either hypothesis. In an important
series of studies, Tanaka et al. [7–9] have used myotubes
derived from cultured newt limb blastema cells to demon-
strate that the plasticity of myofibers in regenerating newt
limbs may be due in part to a unique ability to re-enter the
cell cycle in response to wound factors.  
In two previous papers, Tanaka et al. [7,8] showed that
serum from a variety of sources can stimulate cultured
newt myotubes, but not mouse C2C12 myotubes, to re-
enter the cell cycle and synthesize DNA. In quiescent
cells, an important suppressor of the cell cycle is the
retinoblastoma protein, which binds to transcription factors
that activate genes essential for cell-cycle entry, thus pre-
venting them from acting. Growth factors, which are an
important component of serum, can stimulate receptive
cells to phosphorylate the retinoblastoma protein, releas-
ing it from the transcription factors and sending the cell
into S phase. This serum-stimulated phosphorylation of
retinoblastoma protein is blocked in mouse myotubes, but
not in newt myotubes. But a wide variety of growth factors
that stimulate DNA synthesis in both newt and mouse
myoblasts were unable to evoke DNA synthesis in newt
myotubes. These results suggested that serum contains a
different kind of factor that can stimulate DNA synthesis
in newt myotubes, but not in mouse myotubes. Fractiona-
tion of serum yielded a crude fraction containing growth
factors and thrombin — a crucial enzyme for plasma clot-
ting — that had the stimulatory activity. 
As reported recently in Current Biology, Tanaka et al. [9]
have now shown directly that thrombin is the active com-
ponent in this fraction that regulates cell-cycle re-entry
(Figure 1), and that thrombin activity is elevated early in
newt limb regeneration. They were able to abolish the
stimulatory activity of the crude thrombin fraction of serum
by incubating it with thrombin inhibitors, such as hirudin.
This fraction was further separable into two peaks, 1 and 2;
peak 1 had the stimulatory activity, and further
fractionation yielded pure thrombin. Using a fluorogenic
thrombin substrate they were able to test, on cryostat sec-
tions of regenerating newt limbs, whether thrombin activ-
ity is elevated during the dedifferentiation stage: strong
fluorescence was observed, which was abolished when the
sections were incubated with a thrombin inhibitor.
Further experiments, however, showed that thrombin
does not act directly on newt myotubes. Neither crude
thrombin preparations nor pure thrombin elicited DNA
synthesis unless serum was also present (Figure 1). Prepa-
rations in which serum at a subthreshold concentration —
for DNA synthesis — was incubated with thrombin for
24 hours before the addition of a thrombin inhibitor stimu-
lated DNA synthesis, whereas incubation of the serum
with both thrombin and inhibitor for 24 hours abolished
the stimulatory activity. These results show that cell-cycle
re-entry is stimulated not by thrombin directly, but
indirectly through a serum protein that is activated by
thrombin. This protein was shown to reside in peak 2 of
the fractionated crude thrombin. Peak 2 retains 40% of the
stimulatory activity of the crude thrombin fraction under
serum-free conditions.
Newt myotubes are thus clearly different from mammalian
myotubes in being able to receive and transduce a signal
provided by a thrombin-activated protein in serum that
leads to cell-cycle re-entry and DNA synthesis. This
protein is both necessary and sufficient to stimulate
myotube nuclei to enter S phase. Work is underway to
identify the protein — it is not any of the usual substrates
of thrombin associated with blood clotting — whereupon it
should be possible to determine its receptor(s) and
perhaps the pathway involved in the signal transduction. 
It should be noted that neither serum, the crude thrombin
fraction, nor the factor activated by thrombin, is sufficient
to drive newt myotube nuclei through mitosis; the nuclei
remain arrested in G2 phase of the cell cycle. Both serum
and the crude thrombin fraction promote complete cell
cycling in myoblasts, but neither the peak 1 or 2 fractions
have any effect on newt myoblasts. The action of the
protein thus appears to be specific for newt myotubes,
although possible effects on other mononucleate cells,
such as fibroblasts, skeletal cells or Schwann cells, have
not been tested. The data suggest that mammalian
myotubes and newt and mammalian myoblasts do not
respond to the protein, either because they lack the
protein’s receptor or because there is some factor in these
cells that neutralizes the protein’s activity.
Many questions remain about myofiber dedifferentiation
in regenerating newt limbs. For example, what is the
relationship between dedifferentiation and cell cycling in
myofibers? Multinucleate myofibers are highly differen-
tiated cells which, during regeneration in vivo, break up
into mononucleate cells. Myofiber break up and
dedifferentiation are clearly not required for the protein
identified by Tanaka et al. [9] to stimulate myotube nuclei
to enter S phase, but are they required for the completion
of myonuclear mitosis? Is there a mechanistic link between
myofiber break up, dedifferentiation and the ability to
traverse G2 phase and form a mitotic spindle? How is the
myofiber broken up into mononucleate cells? Is the
protein identified by Tanaka et al. [9] sufficient to induce
complete mitosis once mononucleate cell status has been
attained? Is further proliferation then under the control of
the growth and trophic factors supplied by the limb nerves
and wound epidermis [1,6]? Is entry of myofibers — or
other cell types for that matter — into S phase prior to de-
differentiation the rule in regenerating newt limbs? 
Finally, like mammals, the bones and muscles of the
urodele limb contain reserve osteogenic cells and myoblasts
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Identification of a protein in serum that stimulates nuclei of newt
myotubes, but not those of mouse myotubes or mononucleate cells of
either newt or mouse, to re-enter the cell cycle, in particular to
progress to S phase (and thus undergo DNA replication). The crude
thrombin fraction of serum (far left) was fractionated into two peaks, 1
and 2. Peak 1 was further fractionated to yield pure thrombin, which
when incubated with serum produces an active protein that stimulates
DNA synthesis in newt myotubes, but not in mouse myotubes or
mononucleate cells. Peak 2 contains the active protein, which
stimulates DNA synthesis in newt myotubes in the absence of serum.
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(satellite cells). These cells are activated, proliferate and
regenerate new tissue after a local injury [1]. Although a
contribution of such reserve progenitor cells to the regener-
ation blastema has not been ruled out, it is an interesting
question why the blastema seems to be derived primarily
from the dedifferentiation of mature cells. Perhaps the
sheer number of cells required to regenerate a limb is more
than can be supplied by proliferation of reserve cells alone.
Or perhaps reserve cells do not have a memory of their posi-
tion in the limb that dermal fibroblasts and muscle cells are
known to have stamped upon them during embryogenesis
[10], so that dedifferentiated cells carrying that memory are
essential for the regeneration of the complex tissue pattern
of the limb. Whatever the case, the intrinsic properties of
urodele cells that endow them with their regenerative plas-
ticity deserve more attention; understanding the basis of
these properties may suggest show similar plasticity might
be conferred on mammalian cells. 
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